Maruti Suzuki commences commercial production at second Kharkhoda plant
Maruti Suzuki India · Automobiles
Key highlights
- Second plant at Kharkhoda, Haryana started production on 18th May 2026 with 250,000 units annual capacity
- Total Kharkhoda facility capacity now 500,000 units annually, part of overall 2.65 million units annual production capacity
- Production capacities by location: Gurugram 500,000; Manesar 900,000; Hansalpur 750,000; Kharkhoda 500,000 units annually
Why it's rated notable: Commercial production started at a second Kharkhoda plant of 250,000 units per annum, but the filing states no capex or revenue figure, so the level stays at medium.
Figures checked against the filing by a second AI read. About the business, not the share price.
Original filing
Commencement Of The Commercial Production At Second Plant In Kharkhoda
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Maruti Suzuki India
- Capex / expansionNotableMaruti Suzuki India Limited announces Annual Integrated Report 2025-26 and growth updates
- Capex / expansionNotableMaruti Suzuki India begins commercial production at fourth Hansalpur plant, Gujarat
- Capex / expansionMajor developmentMaruti Suzuki inaugurates Kharkhoda plant, 0.5 million units now, 1 million planned
- Capex / expansionMajor developmentMaruti Suzuki India approves first phase capacity addition of 2.5 lakh vehicles at Khoraj
Other capex / expansion filings this fortnight
- Maharaja & Speedex India Limited raises manufacturing capacity to 72 lakh units/year
- Elin Electronics Q2 FY27 earnings report with 10% revenue growth and margin update
- HOAC Foods India Limited H1 FY27 Earnings Call Transcript dated November 5, 2026
- Gujarat State Fertilizers & Chemicals Limited Q2 FY27 Earnings Call Highlights
- Supriya Lifescience H1 revenue up 14.8% to ₹396.04 crore; Q2 profit falls
- V-MARC India Ltd announces Q2 & H1 FY27 unaudited financial results and review report
Potential multibaggers · Q2 FY27
Potential multibaggers in Automobiles
on management's own guidance
- M & MGood growth2
- Strong growth1
- Bajaj AutoGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.